Our results provide initial evidence that long (≥12 in both alleles) AAT repeats within the CNR1 gene reduce CB1R expression in MS patients, and exacerbate the impact of inflammation on neuronal integrity and function in the optic nerve and in the brain of MS patients. This evidence concerns the gene CNR1 and myeloid sarcoma.